Hemant Surgical Industries Ltd

Hemant Surgical Industries Limited informed the BSE Limited that Bigshare Services Pvt. Ltd. confirmed that Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 is not applicable to the company for the quarter ended September 30, 2026, as all shares are held in demat form and no requests for rematerialization were received.

Hemant Surgical Industries Limited will close its trading window for directors, promoters, designated employees, connected persons, and immediate relatives starting Thursday, October 01, 2026, in connection with the declaration of the company’s unaudited financial results for the half year ending September 30, 2026, according to a filing with the BSE Limited. The trading window will reopen 48 hours after the financial results are declared to the stock exchange.

Hemant Surgical Industries Limited informed the BSE Limited that its Board of Directors approved the Directors’ Report and Management Discussion and Analysis Report for the financial year ended March 31, 2026, and decided to hold the 37th Annual General Meeting of its members on September 29, 2026, at 12:30 P.M. (IST) through video conferencing or other audio-visual means.

Hemant Surgical Industries has completed the strategic acquisition of a majority stake (66.66%) in Lifesenz Cancer Research Labs (Lifesenz), a company focused on precision oncology and personalized cancer treatment solutions for an amount of Rs. 19.98 crore, making Lifesenz a subsidiary of the Company with effect from 01 June 2026.

Hemant Surgical Industries will hold a meeting of the Board of Directors of the Company on 15 May 2026.

Hemant Surgical Industries announced that the purchase orders dated 02 December 2025, 10 December 2025 and 31 December 2025 received from Central Medical Service Society, Ministry of Health and Family Welfare, Government of India (CMSS) for supply of Flat Panel Detector with two batteries and router along with its other utilities for a total consideration of Rs. 264.33 crore (inclusive of all taxes and duties), final commercial terms including delivery schedule, which are still under discussion and finalization, the Company has agreed to commence supplies, in interim, taking into account the national importance of the project and request made by CMSS. The final terms when finalized will be intimated by the Company in due coursePowered by Capital Market - Live

According to an exchange filing, the order pertains to the supply of flat panel detectors with two batteries and a router, hard travel cases along with other utilities, and X-ray generators. The final commercial terms, including the delivery schedule of the purchase orders, are currently under discussion and subject to finalisation. The company stated that the order will be executed in tranches by 30 September 2026, subject to negotiations and terms, including any extension requested by Hemant Surgical Industries to CMSS. Hemant Surgical Industries clarified that none of its promoters or promoter group entities have any interest in the awarding authority. It further stated that the contract does not qualify as a related-party transaction under applicable regulatory norms. Hemant Surgical Industries is in the business of medical equipment & supplies. The company's standalone net profit fell 17% to Rs 8.13 crore on a 0.9% rise in revenue to Rs 106.53 crore in FY25 over FY24. Powered by Capital Market - Live

Hemant Surgical Industries will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live

The order will be executed in tranches by 31 December 2025. Hemant Surgical Industries is in the business of medical equipment & supplies. The company's standalone net profit fell 17% to Rs 8.13 crore on a 0.9% rise in revenue to Rs 106.53 crore in FY25 over FY24.Powered by Capital Market - Live

Hemant Surgical Industries announced that the Annual General Meeting(AGM) of the company will be held on 23 September 2025.Powered by Capital Market - Live